Ovarian Cancer

Cancer Drug Trials Put On Hold After Patients Died

Can Cannabis Help Cure Ovarian Cancer? New Research At Southern Illinois University Shows Promise

Zentalis Pharma Posts Initial Clinical Data On Its Wee1 Inhibitor In Ovarian Cancer

Can Cannabis Help Cure Ovarian Cancer? New Research At Southern Illinois University Shows Promise

Zentalis Pharma Posts Initial Clinical Data On Its Wee1 Inhibitor In Ovarian Cancer

Zai Lab's Niraparib Shows 3X Longer PFS Compared to Placebo In Ovarian Cancer

Why Are ImmunoGen Shares Trading Lower Today

Zai Lab's Niraparib Shows 3X Longer PFS Compared to Placebo In Ovarian Cancer

Why Are ImmunoGen Shares Trading Lower Today

ImmunoGen Shares Rally After Ovarian Cancer Trial Meets Primary Endpoint Goal

Takeda, Shattuck Labs Terminate Immuno-Oncology Pact

Ovarian Cancer Recent News

Bicycle Therapeutics Stock Falls After Interim Data Of Toxin Conjugates In Ovarian Cancer Trial

Why Did Prelude Therapeutics Stock Tumble To 52-Week Low Today?

Verastem Shares Are Trading Higher On Encouraging Combo Therapy Data At ESMO Presentation

Deciphera Presents New Data Across Pipeline At ESMO Congress

Corcept Therapeutics' Relacorilant Combo Therapy Shows Clinical Benefit In Ovarian Cancer

Why Are Mersana Therapeutics Shares Trading Lower On Friday?

Mersana Therapeutics Inc (NASDAQ: MRSN) stock is moving lower during the market trading session. Investors are reacting to interim data from the ovarian cancer Phase 1 trial evaluating Upifitamab Rilsodotin (UpRi, previously XMT-1536).

Anixa Biosciences' CAR-T Therapy To Start Human Trial For Ovarian Cancer

Sutro Biopharma's Ovarian Cancer Candidate Fast Tracked In US

IMV's Shares Jump As Ovarian Cancer Candidate Shows Overall Survival Rate Of 44.9%

Sellas Life Sciences Reports Encouraging Immune Response From GPS Combo Trial In Ovarian Cancer

VBL Therapeutics Shares Drop As Pending Clearance Of New Batches Cancer Gene Therapy Hit Recruitment In Ovarian Cancer Trial

The FDA notified VBL Therapeutics Ltd (NASDAQ: VBLT) that clearance of new VB-111 batches for use in the U.S. is currently pending, as review by the Chemistry, Manufacturing, and Controls (CMC) group is still ongoing.

VBL Therapeutics Stock Jumps on Adding PFS as Second Independent Primary Endpoint in Ovarian Cancer Gene Therapy Trial

Verastem's VS-6766/Defactinib Combo Gets Breakthrough Therapy Tag For Ovarian Cancer; BTIG Upgrades Stock

Cancer Focus Fund To Finance Mereo's Ovarian Cancer Study With Etigilimab

Mersana Therapeutics Starts UpRi Dosing In Heavily Pretreated Cohort Of Ovarian Cancer Patients

Celsion's Ovarian Cancer Immunotherapy Shows 41% Improvement In R0 Resection Rates

Vascular Biogenics' Ovarian Cancer Gene Therapy Shows Response Rate Of Over 58%

Kazia Therapeutics Licenses Cantrixil To Oasmia Pharmaceutical For Ovarian Cancer

Kazia Therapeutics Ltd (NASDAQ: KZIA) has

Celsion's Ovarian Cancer Immunotherapy Shows 38% Improvement In R0 Resection Rates Versus Control Arm

Vascular Biogenics' Ovarian Cancer Gene Therapy Study To Continue, Recommends An Independent Committee

Celsion Receives Fast Track Tag In US For Ovarian Cancer Immunotherapy

Jury Awards Woman $417 Million On Allegation Johnson & Johnson (NYSE: JNJ) Talcum Powder Gave Her Cancer

Clovis Addresses Some Of The Company's Biggest Controversies